Executive Summary
Business Executives are constantly challenged to address competition, improve revenues and generate value for stakeholders. To accomplish this, they need comprehensive information including patents, products and post market safetey intelligence - patient outcomes, adverse event reports, Enforcement reports - Product Recalls and Withdrawals.
Pintels provides BioPharMed Intelligence Solutions - Analytics on Demand, provisions Competitive Intelligence, Patent Intelligence, Product Intelligence, Safety Intelligence - Adverse Event Reporting , Enforcement Reports - Recalls & Withdrawals, Drug Master Files (DMFs) and Bioresearch Monitoring Information System (BMIS) . Executives can also track competitor patent portfolio, patent families, patent classification, patent litigation, Drug Class, Active Ingredients, Formulations, Dosages & Administration information.
Pintels BioPharMed Intelligence solutions include:
-
Competitive Intelligence
-
Patent Intelligence
-
Drug Product Intelligence
-
Post Market Safety Intelligence (SI)
-
Safety Intelligence - Adverse Event Reporting
-
Safety Intelligence - Enforcement Reports - Recalls & Withdrawals
-
Drug Master Files (DMFs)
-
Bioresearch Monitoring Information System (BMIS)
Pintels Bench to Bed Analytics
Pintels Bench to Bed Analytics is the world's first and most comprehensive analytics solution encompassing R&D bench data, capturing ideas, invention disclosures, patents, to products & regulatory information through post market surveillance and Adverse Events, patient drug consumption outcomes. This one stop actionable intelligence solution provides you in-depth information across the entire drug life cycle enabling you to make right decisions at right time to improve product quality or create new products or improve patient outcomes. R&D scientists, CEO's, CXO's, Product Managers, Marketing Managers, Chief IP Counsel, Patent Counsel, IP Executives, Generic and Brand manufacturers can use these intelligence analytics.
Pintels Bench to Bed Analytics combines multiple data points from patents to product to regulatory information to post market surveillance through adverse event intelligence to improve drug product quality to control diseases, reduce risks and improve patient outcomes. The unprecedented intelligence analytics are delivered leveraging big data and analytics, providing actionable intelligence and opportunity to develop better products & superior patient outcomes.